ARTICLE | Company News
Bayer hematology news
March 17, 2014 7:00 AM UTC
Bayer said it will invest more than €500 million ($694.8 million) to establish additional manufacturing capacities of its recombinant Factor VIII ( rFVIII) hemophilia products at its Wuppertal and Lev...